camparison of the effects of surfactant with and without budesonide on the outcomes of neonatal respiratory distress syndrome
Phase 3
- Conditions
- eonatal respiratory distress syndrome.Respiratory distress syndrome of newbornP22.0
- Registration Number
- IRCT20211218053444N3
- Lead Sponsor
- Kerman University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
neonates with respiratory distress syndrome with a gestational age of less than 32 weeks
Exclusion Criteria
severe asphyxia
Severe congenital anomalies
shock
Cardiovascular instability
Lack of parental consent
Maternal chorioamnionitis
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The severity of respiratory distress at birth, which requires surfactant injection based on the respiratory score of newborns. Timepoint: 1?2?3?4?5?6?7?8?9?10 day. Method of measurement: Infants respiratory score.
- Secondary Outcome Measures
Name Time Method ecrotizing enterocolitis:infants who suffer from intestinal wall edema and feeding intolerance. Timepoint: 1?2?3?4?5?6?7?8?9?10 days. Method of measurement: view.;Intraventricular hemorrhage. Timepoint: 1?2?3?4?5?6?7?8?9?10 days. Method of measurement: Brain ultrasound.;Pneumothorax. Timepoint: 1?2?3?4?5?6?7?8?9?10 days. Method of measurement: lung radiography.;Duration of mechanical ventilation. Timepoint: 1?2?3?4?5?6?7?8?9?10 days. Method of measurement: view.;Sepsis. Timepoint: 1?2?3?4?5?6?7?8?9?10 days. Method of measurement: blood culture.